ENTO ENTERO THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Reverse Stock Split First Wave BioPharma, Inc. held a special meeting of stockholders and approved a reverse stock split at a ratio of 1-to-20, increasing the total number of authorized shares of Common Stock to 100,000,000 shares.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC